Agilon Health Inc (AGL) concluded trading on Wednesday at a closing price of $4.26, with 7.63 million shares of worth about $32.5 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 65.12% during that period and on April 30, 2025 the price saw a gain of about 12.11%. Currently the company’s common shares owned by public are about 412.19M shares, out of which, 302.08M shares are available for trading.
Stock saw a price change of 8.67% in past 5 days and over the past one month there was a price change of -1.62%. Year-to-date (YTD), AGL shares are showing a performance of 124.21% which decreased to -14.80% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.50 but also hit the highest price of $7.73 during that period. The average intraday trading volume for Agilon Health Inc shares is 6.08 million. The stock is currently trading -5.87% below its 20-day simple moving average (SMA20), while that difference is up 2.90% for SMA50 and it goes to 15.92% higher than SMA200.
Agilon Health Inc (NYSE: AGL) currently have 412.19M outstanding shares and institutions hold larger chunk of about 71.60% of that.
The stock has a current market capitalization of $1.76B and its 3Y-monthly beta is at 0.40. It has posted earnings per share of -$0.63 in the same period. It has Quick Ratio of 1.27 while making debt-to-equity ratio of 0.09. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AGL, volatility over the week remained 7.33% while standing at 10.53% over the month.
Stock’s fiscal year EPS is expected to rise by 48.29% while it is estimated to increase by 40.63% in next year. EPS is likely to grow at an annualized rate of 48.81% for next 5-years, compared to annual growth of 3.29% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on April 25, 2025 offering a Buy rating for the stock and assigned a target price of $5 to it. Coverage by Bernstein stated Agilon Health Inc (AGL) stock as an Outperform in their note to investors on April 08, 2025, suggesting a price target of $8.50 for the stock. Stock get a Neutral rating from Macquarie on December 16, 2024.
